Prr14 (BC006909) Mouse Tagged ORF Clone Lentiviral Particle
CAT#: MR205081L4V
- LentiORF®
Lenti ORF particles, Prr14 (GFP-tagged) - Mouse proline rich 14 (cDNA clone MGC:6888 IMAGE:2651775), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 11,115.00
货期*
详询
规格
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Prr14 (BC006909) Mouse Tagged ORF Clone Lentiviral Particle |
Synonyms | MGC6888 |
Vector | pLenti-C-mGFP-P2A-Puro |
ACCN | BC006909 |
ORF Size | 1020 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(MR205081).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | BC006909 |
RefSeq Size | 1268 bp |
RefSeq ORF | 1022 bp |
Locus ID | 233895 |
Gene Summary | Functions in tethering peripheral heterochromatin to the nuclear lamina during interphase, possibly through the interaction with heterochromatin protein CBX5/HP1 alpha (By similarity). Might play a role in reattaching heterochromatin to the nuclear lamina at mitotic exit (By similarity). Promotes myoblast differentiation during skeletal myogenesis, possibly by stimulating transcription factor MyoD activity via binding to CBX5/HP1 alpha (PubMed:25906157) (By similarity). Involved in the positive regulation of the PI3K-Akt-mTOR signaling pathway and in promoting cell proliferation, possibly via binding to GRB2 (By similarity).[UniProtKB/Swiss-Prot Function] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...